.
New Delhi, April 26 (MondayMirror.com) The Drugs Controller General of India (DCGI) on Tuesday approved the restricted emergency use authorisation (EUA) to Bharat Biotech’s Covaxin for children between the age of 6-12 years, sources said.
The DGCI has asked vaccine manufacturer to submit safety data including the data on adverse event with due analysis every 15 days for the first two months and monthly thereafter upto 5 months, said the source familiar with the development.
This development comes after the Subject Expert Committee (SEC) discussed recommendations for the restricted emergency use of Covaxin in children aged between 2-12 years.
However, the SEC, after a meeting on Thursday, had recommended restricted emergency use of Biological E’s Covid-19 vaccine, Corbevax, in children aged 5-12 years.
Source: IANS
The way Bollywood promotes films has undergone a remarkable transformation over the past decade. Earlier,…
The Bollywood film industry has experienced a significant transformation in how success is measured. For…
Highlighting the growing role of women in leadership, Rotary Club Chandigarh Midtown (District 3080) witnessed…
Bollywood has always fascinated audiences with its larger-than-life stories, glamorous stars, breathtaking locations, and memorable…
The way Bollywood promotes its films has changed dramatically over the past decade. There was…
The definition of success in Bollywood has changed dramatically over the past decade. There was…